Structured evidence table for Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | The risk of NCDs such as diabetes and cardiovascular disease increases with aging due to a progressive decline in metabolic function [,]. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | The World Health Organization identifies elevated blood glucose level and abnormal lipid profiles as key risk factors for NCDs []. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Moreover, in a previous study, acute intake of 1‐deoxynojirimycin from mulberry leaf extract reduced postprandial blood glucose level more effectively at dinner than at breakfast []. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | 1 2 3 4 5 6 7 The global burden of noncommunicable diseases (NCDs) exceeded 43 million deaths in 2021, making them a major public health concern []. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Beyond sharing common risk factors with metabolic disorders including diabetes, obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular (CV) diseases, CKD is characterized by chronic and prolonged exposure to bioactive metabolites known as uremic toxins (UTs), which exert many deleterious systemic effects. | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Recent experimental and clinical data have nevertheless improved the classification of UTs according to their origin and biological activity, allowing for better identification of actionable sources. | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Therefore, the accumulation and high concentrations of UTs in the bloodstream of CKD patients result from a combination of impaired kidney function leading to reduced clearance, increased de novo production driven by CKD-associated dysbiosis, and enhanced gut permeability (often referred to as “leaky gut”) []. | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Nutrition remains a cornerstone in the management of chronic kidney disease (CKD), acting in synergy with recent pharmacological advances such as sodium–glucose cotransporter 2 inhibitors (SGLT2is), renin–angiotensin–aldosterone system inhibitors (RAASis), and glucagon-like peptide-1 receptor agonists (GLP-1RAs). | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
Source documents